Guzik, T. J. (2021). Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial. JACC Journals.
Chicago Style CitationGuzik, Tomasz J. Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial. JACC Journals, 2021.
MLA CitationGuzik, Tomasz J. Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial. JACC Journals, 2021.
Warning: These citations may not always be 100% accurate.